
Recent Advances and Future Directions in Lung Cancer — With Dr Ibiayi Dagogo-Jack and Stephen Liu (Proceedings from a Symposium in Partnership with NCOA and SCOS)
Lung Cancer Update
00:00
Pneumonitis With Antibiotic Drug Conjugates
The pneumonitis we've seen with antibiotic drug conjugates has not been as sort of long lasting as what we see with immunotherapy. With immunotherapy, we learned early on that when you stop those steroids after three weeks or so, that pneumonitis often will just sort of come right back and we really need these long types of steroids to keep people safe. I think the ADCs are going to play more of a role in the front line setting. But I'm actually, especially for driver positive cancers, I really think cellular therapy is going to play a much bigger role in the years to come. We heard some great talks earlier today about some of the bi-specifics
Transcript
Play full episode